Beth Beadle News Today

Daily adaptive radiotherapy minimized radiation exposure to salivary glands and led to fewer acute toxicities among patients with head and neck cancer.

A randomized controlled trial conducted in 10 low- to middle-income countries showed that 11.5 days could be safely shaved off a conventional fractionation schedule at no cost regarding outcomes.

'Expensive and intensive' process does not translate into clinical benefit, researchers conclude